NCT04254042View on ClinicalTrials.gov

Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients.

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

May 1, 2019

Study Completion Date

May 1, 2019

Conditions
Hypertension
Interventions
DRUG

Perindopril Arginine

10 mg Perindopril tablet / day will be added to the usual treatment for each patient for a period of 8 weeks.

DRUG

Zofenopril, Calcium Salt, (1(R*),2Alpha,4Alpha)-isomer

30 mg Zofenopril tablet / day will be added to the usual treatment for each patient for a period of 8 weeks.

Trial Locations (1)

Unknown

Yaounde Central Hospital, Cardiology department, Yaoundé

All Listed Sponsors
lead

Yaounde Central Hospital

OTHER_GOV

NCT04254042 - Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients. | Biotech Hunter | Biotech Hunter